@article {Walmsley2020.11.10.20227769, author = {Rosemary Walmsley and Shing Chan and Karl Smith-Byrne and Rema Ramakrishnan and Mark Woodward and Kazem Rahimi and Terence Dwyer and Derrick Bennett and Aiden Doherty}, title = {Reallocating time from device-measured sleep, sedentary behaviour or light physical activity to moderate-to-vigorous physical activity is associated with lower cardiovascular disease risk}, elocation-id = {2020.11.10.20227769}, year = {2020}, doi = {10.1101/2020.11.10.20227769}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Moderate-to-vigorous physical activity (MVPA), light physical activity, sedentary behaviour and sleep have all been associated with cardiovascular disease (CVD). Due to challenges in measuring and analysing movement behaviours, there is uncertainty about how the association with incident CVD varies with the time spent in these different movement behaviours.Methods We developed a machine-learning model (Random Forest smoothed by a Hidden Markov model) to classify sleep, sedentary behaviour, light physical activity and MVPA from accelerometer data. The model was developed using data from a free-living study of 152 participants who wore an Axivity AX3 accelerometer on the wrist while also wearing a camera and completing a time use diary. Participants in UK Biobank, a prospective cohort study, were asked to wear an accelerometer (of the same type) for seven days, and we applied our machine-learning model to classify their movement behaviours. Using Compositional Data Analysis Cox regression, we investigated how reallocating time between movement behaviours was associated with CVD incidence.Findings We classified accelerometer data as sleep, sedentary behaviour, light physical activity or MVPA with a mean accuracy of 88\% (95\% CI: 87, 89) and Cohen{\textquoteright}s kappa of 0{\textperiodcentered}80 (95\% CI: 0{\textperiodcentered}79, 0{\textperiodcentered}82). Among 87,509 UK Biobank participants, there were 3,424 incident CVD events. Reallocating time from any behaviour to MVPA, or reallocating time from sedentary behaviour to any behaviour, was associated with a lower risk of CVD. For example, for a hypothetical average individual, reallocating 20 minutes/day to MVPA from all other behaviours proportionally was associated with 9\% (7\%, 10\%) lower risk of incident CVD, while reallocating 1 hour/day to sedentary behaviour was associated with 5\% (3\%, 7\%) higher risk.Interpretation Reallocating time from light physical activity, sedentary behaviour or sleep to MVPA, or reallocating time from sedentary behaviour to other behaviours, was associated with lower risk of incident CVD. Accurate classification of movement behaviours using machine-learning and statistical methods to address the compositional nature of movement behaviours enabled these insights. Public health interventions and guidelines should promote reallocating time to MVPA from other behaviours, as well as reallocating time from sedentary behaviour to light physical activity.Funding Medical Research Council.Competing Interest StatementMW is a consultant to Amgen, Kyowa Kirin and Freeline.Funding StatementThis research has been conducted using the UK Biobank Resource under Application Number 59070. CAPTURE-24 data collection and annotation was supported by the UK Economic and Social Research Council (grant number ES/L011662/1). RW is supported by a Medical Research Council Industrial Strategy Studentship (grant number MR/S502509/1). AD, DB and KR are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). AD and SC are supported by Health Data Research UK, an initiative funded by UK Research and Innovation (UKRI), Department of Health and Social Care (England) and the devolved administrations, and leading medical research charities. AD and SC are supported by the Alan Turing Institute and the British Heart Foundation (grant number SP/18/4/33803). MW is supported by National Health and Medical Research Foundation of Australia grants 1080206 and 1149987. KR is supported by: the PEAK Urban programme, UKRI{\textquoteright}s Global Challenge Research Fund, Grant Ref: ES/P011055/; the Oxford Martin School (OMS), University of Oxford; and the British Heart Foundation, Grant ref: PG/18/65/33872. Computation used the Oxford Biomedical Research Computing (BMRC) facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the UK National Health Service, the NIHR, the OMS, or the Department of Health and Social Care. The funding organisations had no role in design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank studies received general ethical approval from the NHS National Research Ethics Service (Ref 11/NW/0382). CAPTURE-24 received ethical approval from the University of Oxford Inter-Divisional Research Ethics Committee (Ref SSD/CUREC1A/13-262).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank data is available to researchers who submit an application (https://www.ukbiobank.ac.uk/). The summary physical activity, sedentary behaviour, and sleep variables that we have developed will be made available as a part of the UK Biobank Returns Catalogue (https://biobank.ndph.ox.ac.uk/showcase/docs.cgi?id=1). Code for accelerometer data processing, feature extraction, machine-learning, and Compositional Data Analysis is available at https://github.com/activityMonitoring. https://www.ukbiobank.ac.uk/ https://github.com/activityMonitoring}, URL = {https://www.medrxiv.org/content/early/2020/11/20/2020.11.10.20227769.1}, eprint = {https://www.medrxiv.org/content/early/2020/11/20/2020.11.10.20227769.1.full.pdf}, journal = {medRxiv} }